Research and Publications
Dr Chakrabarti has authored multiple articles and research papers that have been published in renowned peer-reviewed journals worldwide, including in New Zealand, South Africa, and England. His published works include contributions to:
● RSSDI Monograph on Insulin
● Manual of Lipidology
In total, he has published nearly 50 articles in various national and international journals, contributing to the advancement of knowledge in endocrinology and metabolic disorders.
Media and Public Outreach
Committed to educating the public about diabetes and other endocrine disorders, Dr. Chakrabarti has recorded several informative sessions, such as:
● "Myths in Diabetes"
● "Diabetic Diet"
These sessions have been broadcast on major platforms, including NDTV, News18 Bangla, radio, and print media, helping raise awareness about diabetes management and healthy living.
Research and Clinical Trials
Dr Chakrabarti has been involved in several cutting-edge research initiatives, including being the Principal Investigator in a pioneering study on “Biofilm & Microbiome in Diabetic Foot Ulcer and its Outcome.” This study, funded by the Department of Science and Technology, Government of India, was a joint collaboration between SSKM Hospitals and the Biomedical Genomic Centre.
In addition to this, he has been a key investigator in numerous other clinical trials, further advancing the understanding and treatment of endocrine disorders.
Speaking Engagements
A sought-after speaker at national and international conferences, Dr. Chakrabarti has shared his expertise at several prestigious events, including:
● ITSCON 2015
● AESCON, Guwahati 2017
● IDEACON, Kolkata 2017
● EASD, Barcelona 2019
● APICON West Bengal Midterm Edition 2021
● IDEACON 2023
● CRESCENDO 2023
● INNER CIRCLE MEET, Goa 2023
● CRESCENDO 2024
His presentations often focus on the latest advancements in diabetes care, thyroid management, and endocrine research, making him a recognized voice in the global medical community.
Advisory Roles
Dr Chakrabarti is an advisory board member for several leading pharmaceutical companies, contributing to the development of innovative treatments. His advisory roles include working with: USV, Bayer, Glenmark, BI, Cipla, Abbott, Torrent, Microlabs, Lupin, Glenmark, Sanofi, Zydus
These partnerships enable him to stay at the forefront of medical innovations and ensure his patients receive the best care possible.